Andy NelsonIndustrial PhD Candidate at AstraZeneca (John Hopkins University)Speaker
Profile
Andy is a chemical engineer with over seven years of experience in the pharmaceutical industry. He has conducted his PhD research with AstraZeneca’s Cell Line Development team in Gaithersburg, Maryland, focusing on enrichment strategies during single cell cloning and high-throughput microscopy productivity/screening assays. He is co-advised by Dr. Lina Chakrabarti, of AstraZeneca, and professor Michael Betenbaugh, director of the Advanced Mammalian Biomanufacturing Innovation Center at Johns Hopkins. After graduating with his bachelor’s from Vanderbilt University, he worked in Central America for two years, improving his Spanish and seeing more of the world. Similarly, he’s excited to work in DACH after completing his doctoral studies. Prior to returning to graduate school, he worked in various small molecule API manufacturing roles, most recently as a process manager with Thermo Fisher. As such, he’s keen to bring his operational experience and analytical skills to support translating innovations in bioprocess development.
Agenda Sessions
Endoplasmic reticulum-targeted fluorescent sorting enables early enrichment of high recombinant protein-producing CHO cell lines
, 14:50View Session
